A comprehensive view of Olympus America Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Olympus reports positive policy changes by commercial payers is extending coverage for iTind, its minimally invasive treatment for benign prostatic hyperplasia; policy updates may affect up to 27 million enrollees in the US
Published:
April 15, 2024
by Olympus America Inc.
|
Olympus announces full market availability of new ESG-410 Surgical Energy Platform, which will be on display at the annual meeting of the Society of Thoracic Surgeons in San Antonio, Texas, Jan. 27-29
Published:
January 24, 2024
by Olympus America Inc.
|
Olympus Corporation completes acquisition of Taewoong Medical, a South Korea-based manufacturer of gastrointestinal medical devices; US$370M deal strengthens Olympus's Therapeutic Solutions Division, expands its GI EndoTherapy product offerings
Published:
January 24, 2024
by Olympus America Inc.
|
Olympus launches its next-generation EVIS X1 endoscopy system and will demonstrate it at American College of Gastroenterology annual meeting; system designed to enhance the visualization capability of lesions, polyps, deep blood vessels, bleeding points
Published:
October 19, 2023
by Olympus America Inc.
|
Olympus Latin America to debut next-gen EVIS X1 endoscopy system for the first time at two major events in Mexico and Chile, with full market availability expected next year; system enhances visibility of lesions, polyps, blood vessels, bleeding points
Published:
September 21, 2023
by Olympus America Inc.
|
Ask us about our Health Care Sector market view